pioglitazone group

DRUG2 trials

Sponsors

Xiang Guang-da, my self

Conditions

Digestive SystemEndothelial FunctionLVMType 2 Diabetic Patients With IHD

Phase 4

Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease

CompletedNCT01947790

Xiang Guang-daEndothelial Function, LVM, Type 2 Diabetic Patients With IHD

Start: 2013-09-30End: 2015-07-31Updated: 2015-08-19

Efficacy of pioglitazone in the treatment of metabolic dysfunction-associated fatty liver disease

Active, not recruitingPACTR202502652902049

my selfDigestive System

Start: 2022-06-01Target: 150Updated: 2026-01-27